F4‐03‐02: NEUROPATHOLOGICAL SUBSTRATE OF IMAGING BIOMARKERS ‐ VALIDATING NEUROIMAGING BIOMARKERS IN AD USING HIGH‐RESOLUTION 3D HISTOLOGICAL MAPPING. (1st July 2019)